Buys
Open market- Shares
- Avg price
- Total value
Samarth Kulkarni - Chief Executive Officer, Director at CRISPR Therapeutics AG
Issuer-level insider activity
- Role
- Chief Executive Officer, Director
- Issuer ticker
- CRSP on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Samarth Kulkarni in CRISPR Therapeutics AG
Sells
Open market- Shares
- -182,271
- Avg price
- $59.02
- Total value
- -$10,756,932
Net
Past year- Shares
- -182,271
- Share %
- -100%
- Total value
- -$10,756,932
Reported holdings for Samarth Kulkarni in CRISPR Therapeutics AG
Form 4 holding
Chief Executive Officer, Director
CRISPR Therapeutics AG
- Security class
- Common Shares
- Shares / value
- 255,501
- Estimated value
- $11,952,336
- Report date
- 23 Mar 2026
- Price
- $46.78
- Ownership
- Direct
Form 4 holding
Chief Executive Officer, Director
CRISPR Therapeutics AG
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 114,249
- Estimated value
- Report date
- 20 Mar 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
Form 4 holding
Chief Executive Officer, Director
CRISPR Therapeutics AG
- Security class
- Restricted Stock Units
- Shares / value
- 39,375
- Estimated value
- Report date
- 20 Mar 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
Transaction history for Samarth Kulkarni in CRISPR Therapeutics AG
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.